400 Participants Needed

Digital Health + Community Support for Pregnancy Complications

(P3OPPY Trial)

R"
Overseen ByRosylen "Roz" Quinney
Age: < 65
Sex: Female
Trial Phase: Academic
Sponsor: University of Alabama at Birmingham
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

What data supports the effectiveness of this treatment?

Research shows that community health worker (CHW) programs can improve maternal and child health outcomes, especially in low-resource settings. CHWs have been effective in increasing knowledge about pregnancy and infant health, improving access to antenatal care, and reducing infant and neonatal mortality.12345

Is the combination of digital health and community support safe for pregnancy complications?

Community health worker (CHW) programs, which often include digital health tools, are generally considered safe and have been used effectively to support maternal and child health in various settings. While specific safety data for pregnancy complications is not detailed, CHWs have been trusted to provide community-based health services without significant safety concerns.13678

How is the Digital Health + Community Support treatment for pregnancy complications different from other treatments?

This treatment is unique because it combines the support of community health workers (CHWs) with digital health tools, like smartphones or tablets, to improve pregnancy outcomes. CHWs provide personalized support and education, while digital tools help them stay updated and connected, making it a more accessible and supportive approach compared to traditional methods.12369

What is the purpose of this trial?

The PᵌOPPY study is designed to support the American Heart Association's mission to improve maternal/infant health outcomes and address inequities in maternal/infant health care. The P3OPPY Project is one of five projects within the American Heart Association P3 EQUATE Network. The overarching goal of the P3 EQUATE American Heart Association Health Equity Research Network (HERN) is to promote equity in Maternal and Infant Health outcomes by identifying innovative and cost-effective strategies to enhance access to quality health information, care, and experiences during pregnancy, postnatal and postpartum/preconception periods, particularly for Black and under-served populations. Collectively, the investigators will collaborate with pregnant and postpartum individuals and their families, hospitals, and communities to discover ways to reduce racism and social problems that contribute to poor health outcomes. In this trial, 400 non-Hispanic Black participants will be randomized to see if 2 promising interventions (digital health interventions and community health workers) reduce adverse pregnancy outcomes.

Research Team

WC

Wally Carlo, MD

Principal Investigator

University of Alabama at Birmingham

RS

Rachel Sinkey, MD

Principal Investigator

University of Alabama at Birmingham

Eligibility Criteria

The POPPY trial is for non-Hispanic Black individuals experiencing pregnancy complications. It aims to support maternal/infant health, focusing on those facing healthcare inequities. Participants should be dealing with pregnancy issues and willing to engage with digital and community-based interventions.

Inclusion Criteria

I am between 16 and 49 years old.
Live singleton or dichorionic twin gestation
Dating sonogram at <23 weeks gestation
See 6 more

Exclusion Criteria

Speaks or writes in languages other than English
I choose not to be randomly assigned to a treatment group.
Participated in POPPY Pilot
See 3 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive routine prenatal care services and are randomized to receive either Digital Health Intervention, Community Health Worker intervention, both, or usual care

Duration of pregnancy
Regular prenatal visits

Postpartum Follow-up

Participants are monitored for maternal and neonatal outcomes, including adverse events and postpartum care

6 weeks postpartum
Outpatient visits as needed

Treatment Details

Interventions

  • Community Health Worker
  • Digital Health Intervention
Trial Overview This study tests if a combination of digital health tools and community health worker support can improve pregnancy outcomes compared to each intervention alone. The goal is to see which method better reduces complications during pregnancy in underserved populations.
Participant Groups
4Treatment groups
Experimental Treatment
Active Control
Group I: Digital Health Intervention (DHI)Experimental Treatment1 Intervention
This group will receive routine prenatal care services. Additionally, those randomized to this arm will receive a DHI intervention. A modified DHI will be utilized that was developed by Memora Health in conjunction with EQUATE partners at UPenn and feedback from the POPPY Study Team and Community Advisory Board. All content is designed for 7th grade Flesch-Kincaid level or lower.
Group II: DHI Plus CHWExperimental Treatment1 Intervention
This group will receive routine prenatal care services. Additionally, this group will receive both DHI and CHW interventions.
Group III: Community health worker (CHW)Experimental Treatment1 Intervention
Individuals randomized to this group will receive routine prenatal care services. Additionally, they will receive a CHW intervention. The CHW intervention will be adapted from an ongoing CHW program in Jefferson County, AL called "From Day One (FDO)", a comprehensive patient-centered program designed to educate and provide non-clinical, psychosocial, emotional support to expectant mothers from the 1st trimester of pregnancy through 12 weeks postpartum. The intervention has been modified by the POPPY Study Team and Community Advisory Board
Group IV: Usual CareActive Control1 Intervention
This group will receive routine prenatal care services.

Community Health Worker is already approved in United States for the following indications:

🇺🇸
Approved in United States as Community Health Worker for:
  • Support for diabetes technology use in type 1 diabetes

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Alabama at Birmingham

Lead Sponsor

Trials
1,677
Recruited
2,458,000+

Memora Health

Collaborator

Trials
2
Recruited
440+

American Heart Association

Collaborator

Trials
352
Recruited
6,196,000+

ConnectionHealth

Collaborator

Trials
2
Recruited
440+

Findings from Research

Community health workers (CHWs) foster trust-based relationships with perinatal women, which significantly enhance their prenatal care experience and health outcomes, as reported by 39 clients in focus groups and interviews.
These relationships provide essential emotional, informational, and instrumental support, leading to improved engagement with healthcare, better health behaviors, and reduced stress, highlighting the importance of trust-building in community health programs.
Features and Impact of Trust-Based Relationships Between Community Health Workers and Low-Resource Perinatal Women with Chronic Health Conditions.Boyd, LM., Mehra, R., Thomas, J., et al.[2021]
Community health worker (CHW) interventions have been shown to improve knowledge related to pregnancy and infant health, as well as increase the receipt of antenatal care, with 10 out of 123 studies indicating positive outcomes.
CHWs, who are often local community members, play a crucial role in health education and home visits, and their effectiveness is enhanced when they collaborate with clinical providers to improve maternal and child health outcomes.
Community Health Worker Impact on Knowledge, Antenatal Care, And Birth Outcomes: A Systematic Review.Scharff, D., Enard, KR., Tao, D., et al.[2022]
Community health worker (CHW) interventions, particularly those involving home visits and women's groups, can improve equitable access to maternal and newborn health services in low-income and middle-income countries, as shown in a review of 22 studies.
While some CHW interventions have successfully reduced health inequities, others have not, indicating that the effectiveness of these programs can vary based on the type of intervention and the support provided to CHWs in their communities.
Effects of community health worker interventions on socioeconomic inequities in maternal and newborn health in low-income and middle-income countries: a mixed-methods systematic review.Blanchard, AK., Prost, A., Houweling, TAJ.[2022]

References

Features and Impact of Trust-Based Relationships Between Community Health Workers and Low-Resource Perinatal Women with Chronic Health Conditions. [2021]
Community Health Worker Impact on Knowledge, Antenatal Care, And Birth Outcomes: A Systematic Review. [2022]
Effects of community health worker interventions on socioeconomic inequities in maternal and newborn health in low-income and middle-income countries: a mixed-methods systematic review. [2022]
Adapting a health video library for use in Afghanistan: provider-level acceptability and lessons for strengthening operational feasibility. [2021]
Expanding the population coverage of evidence-based interventions with community health workers to save the lives of mothers and children: an analysis of potential global impact using the Lives Saved Tool (LiST). [2022]
Community Health Worker Use of Smart Devices for Health Promotion: Scoping Review. [2023]
Training and experience outperform literacy and formal education as predictors of community health worker knowledge and performance, results from Rongo sub-county, Kenya. [2023]
Trust of community health workers influences the acceptance of community-based maternal and child health services. [2022]
The use of low-cost ruggedized Android tablets to augment in-service training of community health workers in Mukono, Uganda: perspectives and lessons learned from the field. [2022]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security